Loss of TCEAL4 Expression in Anaplastic Thyroid Cancer
Author Information
Author(s): Akaishi Junko, Onda Masamitsu, Okamoto Junichi, Miyamoto Shizuyo, Nagahama Mitsuji, Ito Kouichi, Yoshida Akira, Shimizu Kazuo
Primary Institution: Nippon Medical School
Hypothesis
The study investigates the role of TCEAL4 in the carcinogenesis of anaplastic thyroid cancer (ATC).
Conclusion
The study suggests that loss of TCEAL4 expression might be associated with the development of ATC from differentiated thyroid cancer.
Supporting Evidence
- TCEAL4 was down-regulated in all 11 anaplastic thyroid cancer samples compared to normal thyroid tissues.
- TCEAL4 was expressed in all normal human tissues tested.
- This is the first report of altered TCEAL4 expression in human cancers.
Takeaway
This study found that a gene called TCEAL4 is not working properly in a type of thyroid cancer, which might help explain how this cancer develops.
Methodology
The study examined TCEAL4 expression levels in anaplastic thyroid cancers and compared them to normal thyroid tissues and other thyroid cancer types using cDNA microarray analysis.
Limitations
The study could not examine protein expression of TCEAL4 due to the unavailability of an appropriate antibody.
Participant Demographics
The study included patients undergoing surgery for thyroid cancer, with a mix of normal thyroid tissue and anaplastic thyroid cancer samples.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website